Find therapies in clinical trials near you – page 241

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Study of Encorafenib and Binimetinib for Patients with BRAF V600-Mutant Non-Small Cell Lung Cancer

Study of Encorafenib and Binimetinib for Patients with BRAF V600-Mutant Non-Small Cell Lung Cancer

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

Study on the Effects of AZD4604 on Airway Inflammation in Adults with Asthma

Study on the Effects of AZD4604 on Airway Inflammation in Adults with Asthma

Study of JDQ443, TNO155, and Tislelizumab for Patients with Advanced Solid Tumors with KRAS G12C Mutation

Study of JDQ443, TNO155, and Tislelizumab for Patients with Advanced Solid Tumors with KRAS G12C Mutation

Study on KER-050 and Ruxolitinib for Patients with Myelofibrosis and Anemia

Study on KER-050 and Ruxolitinib for Patients with Myelofibrosis and Anemia

Study of IMGN632, Venetoclax, and Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

Study of BMS-986446 for Early Alzheimer's Disease Patients

Study of BMS-986446 for Early Alzheimer's Disease Patients

Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis

Study on Tralokinumab for Children Aged 6-11 with Moderate-to-Severe Atopic Dermatitis